Clearmind Medicine

Clearmind is a psychedelic pharmaceutical biotechnology company dedicated to the discovery and development of novel psychedelic-derived therapies to address widespread and underserved health issues, including alcohol use disorder. The company's primary goal is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated drugs, food, or supplements. The company's intellectual property portfolio currently includes 14 patent families. Clearmind intends to file additional patents for its compounds when necessary and will continue to opportunistically acquire more intellectual property to build out its IP portfolio.